Early colon screening of adult patients with cystic fibrosis reveals high incidence of adenomatous colon polyps

Journal of Clinical Gastroenterology

Volumn 48, Issue 9, 2014, Pages e85-e88

  Billings, Joanne L ^a   Dunitz, Jordan M ^a   McAllister, Sandra ^a   Herzog, Tyler ^a   Bobr, Aleh ^a   Khoruts, Alexander ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Colon cancer; Colon polyps; Cystic fibrosis

Indexed keywords

ADENOMATOUS POLYP; ADULT; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER SCREENING; CLINICAL ARTICLE; COLON CANCER; COLON POLYP; COLONOSCOPY; COLORECTAL CANCER; CYSTIC FIBROSIS; EARLY DIAGNOSIS; ENDOSCOPIST; FEMALE; HUMAN; MALE; MIDDLE AGED; PRIORITY JOURNAL; REVIEW; SEX DIFFERENCE;

EID: 85027934344     PISSN: 01920790     EISSN: 15392031     Source Type: Journal    
DOI: 10.1097/MCG.0000000000000034     Document Type: Review

References (43)

1. Farrell PM. The prevalence of cystic fibrosis in the European Union. J Cyst Fibros. 2008;7:450-453
2. Marshall BC, Penland CM, Hazle L, et al. Cystic fibrosis foundation: achieving the mission. Respir Care. 2009;54:788-795; discussion 795
3. Salvatore D, Buzzetti R, Baldo E, et al. An overview of international literature from cystic fibrosis registries. Part 4: Update 2011. J Cyst Fibros. 2012;11:480-493
4. Parkins MD, Parkins VM, Rendall JC, et al. Changing epidemiology and clinical issues arising in an ageing cystic fibrosis population. Ther Adv Respir Dis. 2011;5:105-119
5. Wilschanski M, Durie PR. Patterns of GI disease in adulthood associated with mutations in the CFTR gene. Gut. 2007;56: 1153-1163
6. Neglia JP, FitzSimmons SC, Maisonneuve P, et al. The risk of cancer among patients with cystic fibrosis. Cystic Fibrosis and Cancer Study Group. N Engl J Med. 1995;332:494-499
7. Hernandez-Jimenez I, Fischman D, Cheriyath P. Colon cancer in cystic fibrosis patients: is this a growing problem? J Cyst Fibros. 2008;7:343-346
8. Alexander CL, Urbanski SJ, Hilsden R, et al. The risk of gastrointestinal malignancies in cystic fibrosis: case report of a patient with a near obstructing villous adenoma found on colon cancer screening and Barrett's esophagus. J Cyst Fibros. 2008;7:1-6
9. Meyer KC, Francois ML, Thomas HK, et al. Colon cancer in lung transplant recipients with CF: increased risk and results of screening. J Cyst Fibros. 2011;10:366-369
10. Maisonneuve P, FitzSimmons SC, Neglia JP, et al. Cancer risk in nontransplanted and transplanted cystic fibrosis patients: a 10-year study. J Natl Cancer Inst. 2003;95:381-387
11. Maisonneuve P, Marshall BC, Knapp EA, et al. Cancer risk in cystic fibrosis: a 20-year nationwide study from the United States. J Natl Cancer Inst. 2013;105:122-129
12. Johannesson M, Askling J, Montgomery SM, et al. Cancer risk among patients with cystic fibrosis and their first-degree relatives. Int J Cancer. 2009;125:2953-2956
13. Winawer SJ, Zauber AG, Ho MN, et al. Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med. 1993;329:1977-1981
14. Espey DK, Wu XC, Swan J, et al. Annual report to the nation on the status of cancer, 1975-2004, featuring cancer in American Indians and Alaska Natives. Cancer. 2007;110:2119-2152
15. Selby JV, Friedman GD, Quesenberry CP Jr, et al. A casecontrol study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med. 1992;326:653-657
16. Hardcastle JD, Chamberlain JO, Robinson MH, et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet. 1996;348:1472-1477
17. Kronborg O, Fenger C, Olsen J, et al. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet. 1996;348:1467-1471
18. Mandel JS, Church TR, Bond JH, et al. The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med. 2000;343:1603-1607
19. Zauber AG, Winawer SJ, O'Brien MJ, et al. Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. N Engl J Med. 2012;366:687-696
20. Levin B, Lieberman DA, McFarland B, et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology. 2008;134:1570-1595
21. Rex DK, Johnson DA, Anderson JC, et al. American College of Gastroenterology guidelines for colorectal cancer screening 2009 [corrected]. Am J Gastroenterol. 2009;104:739-750
22. McCashland TM, Brand R, Lyden E, et al. Gender differences in colorectal polyps and tumors. Am J Gastroenterol. 2001;96: 882-886
23. Regula J, Rupinski M, Kraszewska E, et al. Colonoscopy in colorectal-cancer screening for detection of advanced neoplasia. N Engl J Med. 2006;355:1863-1872
24. Brenner H, Hoffmeister M, Arndt V, et al. Gender differences in colorectal cancer: implications for age at initiation of screening. Br J Cancer. 2007;96:828-831
25. El Sayed AM, Kanafani ZA, Mourad FH, et al. A randomized single-blind trial of whole versus split-dose polyethylene glycolelectrolyte solution for colonoscopy preparation. Gastrointest Endosc. 2003;58:36-40
26. Belsey J, Crosta C, Epstein O, et al. Meta-analysis: the relative efficacy of oral bowel preparations for colonoscopy 1985-2010. Aliment Pharmacol Ther. 2012;35:222-237
27. Imperiale TF, Wagner DR, Lin CY, et al. Results of screening colonoscopy among persons 40 to 49 years of age. N Engl J Med. 2002;346:1781-1785
28. Hong SN, Kim JH, Choe WH, et al. Prevalence and risk of colorectal neoplasms in asymptomatic, average-risk screenees 40 to 49 years of age. Gastrointest Endosc. 2010;72: 480-489
29. Thoma MN, Castro F, Golawala M, et al. Detection of colorectal neoplasia by colonoscopy in average-risk patients age 40-49 versus 50-59 years. Dig Dis Sci. 2011;56: 1503-1508
30. Starr TK, Allaei R, Silverstein KA, et al. A transposon-based genetic screen in mice identifies genes altered in colorectal cancer. Science. 2009;323:1747-1750
31. Mehta A. Cystic fibrosis as a bowel cancer syndrome and the potential role of CK2. Mol Cell Biochem. 2008;316:169-175
32. Kerbiriou M, Teng L, Benz N, et al. The calpain, caspase 12, caspase 3 cascade leading to apoptosis is altered in F508del-CFTR expressing cells. PLoS One. 2009;4:e8436
33. Garcia MA, Yang N. Quinton PM. Normal mouse intestinal mucus release requires cystic fibrosis transmembrane regulator-dependent bicarbonate secretion. J Clin Invest. 2009;119: 2613-2622
34. Voynow JA, Selby DM, Rose MC. Mucin gene expression (MUC1, MUC2, and MUC5/5AC) in nasal epithelial cells of cystic fibrosis, allergic rhinitis, and normal individuals. Lung. 1998;176:345-354
35. Kreda SM, Davis CW, Rose MC. CFTR mucins, and mucus obstruction in cystic fibrosis. Cold Spring Harb Perspect Med. 2012;2:a009589
36. Velcich A, Yang W, Heyer J, et al. Colorectal cancer in mice genetically deficient in the mucin Muc2. Science. 2002;295: 1726-1729
37. Norkina O, Burnett TG, De Lisle RC. Bacterial overgrowth in the cystic fibrosis transmembrane conductance regulator null mouse small intestine. Infect Immun. 2004;72:6040-6049
38. Gallagher AM, Gottlieb RA. Proliferation, not apoptosis, alters epithelial cell migration in small intestine of CFTR null mice. Am J Physiol Gastrointest Liver Physiol. 2001;281: G681-G687
39. Abreu MT. Toll-like receptor signalling in the intestinal epithelium: how bacterial recognition shapes intestinal function. Nat Rev Immunol. 2010;10:131-144
40. Rakoff-Nahoum S, Medzhitov R. Toll-like receptors and cancer. Nat Rev Cancer. 2009;9:57-63
41. Arthur JC, Perez-Chanona E, Muhlbauer M, et al. Intestinal inflammation targets cancer-inducing activity of the microbiota. Science. 2012;338:120-123
42. Deeb KK, Trump DL, Johnson CS. Vitamin D signalling pathways in cancer: potential for anticancer therapeutics. Nat Rev Cancer. 2007;7:684-700
43. Smith BK, Robinson LE, Nam R, et al. Trans-fatty acids and cancer: a mini-review. Br J Nutr. 2009;102:1254-1266.